Skip to Content

LeMaitre Vascular Inc LMAT

Morningstar Rating
$83.59 +2.21 (2.72%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

LMAT is trading at a 550% premium.
Price
$83.89
Fair Value
$61.18
Uncertainty
High
1-Star Price
$475.87
5-Star Price
$52.95
Economic Moat
Kfvmpfd
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if LMAT is a good fit for your portfolio.

Trading Information

Previous Close Price
$81.38
Day Range
$80.6683.81
52-Week Range
$44.2783.81
Bid/Ask
$77.21 / $131.90
Market Cap
$1.88 Bil
Volume/Avg
180,999 / 118,471

Key Statistics

Price/Earnings (Normalized)
54.99
Price/Sales
9.41
Dividend Yield (Trailing)
0.72%
Dividend Yield (Forward)
0.77%
Total Yield
0.72%

Company Profile

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Growth
Total Number of Employees
630

Competitors

Valuation

Metric
LMAT
BSX
MDT
Price/Earnings (Normalized)
54.9935.6614.99
Price/Book Value
6.085.632.08
Price/Sales
9.417.643.28
Price/Cash Flow
35.7932.4214.59
Price/Earnings
LMAT
BSX
MDT

Financial Strength

Metric
LMAT
BSX
MDT
Quick Ratio
5.170.941.46
Current Ratio
7.571.662.30
Interest Coverage
8.888.86
Quick Ratio
LMAT
BSX
MDT

Profitability

Metric
LMAT
BSX
MDT
Return on Assets (Normalized)
11.92%9.16%7.75%
Return on Equity (Normalized)
13.75%16.77%13.75%
Return on Invested Capital (Normalized)
12.09%11.67%9.87%
Return on Assets
LMAT
BSX
MDT
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
HxfxrjsdmYbgdh$154.3 Bil
Becton Dickinson & Co
BDX
YmfwwdlbMgwslt$67.5 Bil
Alcon Inc
ALC
YmlxndpQvyxpc$43.7 Bil
ResMed Inc
RMD
DgkwqrzlsYzsdww$31.2 Bil
Coloplast A/S ADR
CLPBY
LwqpmsgnxsMymy$26.9 Bil
West Pharmaceutical Services Inc
WST
QvfbqrckbhQqnd$23.6 Bil
The Cooper Companies Inc
COO
RzzkcyhlSccqbs$18.3 Bil
Baxter International Inc
BAX
WlnsywsbMmdnqv$17.2 Bil
Hologic Inc
HOLX
TnghjtyNxldlj$16.7 Bil
AptarGroup Inc
ATR
JlhlbgkFtvwm$9.7 Bil

Sponsor Center